Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Endogenous opiates may affect various aspects of reproductive and metabolic function in patients with polycystic ovary syndrome (PCOS). This study evaluated long-term inhibition of the opioid system using naltrexone in clomiphene citrate (CC)-resistant women with PCOS. METHODS: A group of 30 infertile females with PCOS were evaluated; all subjects were obese, hyperandrogenic and hyperinsulinemic; 16 patients were amenorrhic and 14 were oligomenorrhic. All subjects received natrexone (50 mg p.o. daily) for 6 months. Patients who did not ovulate after 12 weeks of naltrexone monotherapy, also received CC (starting at 50 mg/day for 5 days and, for non-responders, increasing it up to 150 mg/day). RESULTS: Of the 30 women, 3 ovulated during naltrexone monotherapy and 19 of the remaining 27 ovulated during naltrexone + CC therapy. There were no conceptions during naltrexone monotherapy, but 9 of 27 women (33.3%) conceived during naltrexone + CC; there was one missed abortion at 9 weeks, one preterm delivery at 34 weeks and seven term live births. Naltrexone therapy was also followed by significant reductions in BMI, fasting serum insulin, luteinizing hormone (LH), LH/follicle-stimulating hormone ratio and testosterone. CONCLUSIONS: In this preliminary trial, naltrexone improved endocrine and metabolic function in women with CC-resistant PCOS. Furthermore, naltrexone restored CC sensitivity in the majority of subjects, resulting in a significant number of pregnancies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although some studies have been inconclusive,75,76 the opioid antagonist naltrexone is effective in reducing endocrine symptoms in women with PCOS,77–79 also suggesting that high β-endorphin levels are a feature of this condition.”
From Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone (2023) · cites this paper as [78]
Citations
Cites
Journal of Clinical Psychiatry
(2018) · Journal of Clinical Psychiatry · doi:10.5505/kpd · Cited by 13,651
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712 · cited 1×
“Prevalence of PCOS has been studied in several populations and it appears that it affects as many as 5–10% of women of reproductive age (Diamanti-Kandarakis et al., 1999; Azziz et al., 2004).”
BackgroundCLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506 · cited 2×
“METHODS: A group of 30 infertile females with PCOS were evaluated; all subjects were obese, hyperandrogenic and hyperinsulinemic; 16 patients were amenorrhic and 14 were oligomenorrhic.”
BackgroundMethodDiamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110 · cited 1×
“Prevalence of PCOS has been studied in several populations and it appears that it affects as many as 5–10% of women of reproductive age (Diamanti-Kandarakis et al., 1999; Azziz et al., 2004).”
BackgroundPrevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism.
Adams, J., Polson, D. W., & Franks, S. (1986) · BMJ · doi:10.1136/bmj.293.6543.355 · Cited by 981 · cited 1×
“Polycystic ovarian morphology was diagnosed as the presence of more than 12 follicles (2004) with diameter 8 mm arranged peripherally or scattered throughout an echodense core of stroma (Adams et al., 1986; Polson et al., 1988).”
BackgroundPOLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
Polson, D. W., Wadsworth, J., Adams, J., & Franks, S. (1988) · The Lancet · doi:10.1016/s0140-6736(88)91612-1 · Cited by 906
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743 · cited 2×
“These effects may be related to a decreased LH and improvement of hyperinsulinemia, resulting in lower ovarian androgen production (Nestler and Jakubowicz, 1996).”
BackgroundLegro, R. S., Finegood, D., & Dunaif, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5054 · Cited by 673 · cited 2×
“5 mg/unit are consistent with insulin resistance (Legro et al., 1998).”
BackgroundInfluential
Research works printed but not linked: 3
- Guido, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 1742, 10.1210/jc.83.5.1742 · doi:10.1210/jc.83.5.1742
- Malcolm, 1986, NIDA research monograph, 75, 371
- 1988, 1, 870
Cited by
The effects of opioids and opioid analogs on animal and human endocrine systems
Vuong, C., Van Uum, S. H. M., O'Dell, L. E., Lutfy, K., & Friedman, T. C. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0009 · Cited by 564
Jedel, E., Labrie, F., Odén, A., Holm, G., Nilsson, L., Janson, P. O., Lind, A.-K., Ohlsson, C., & Stener-Victorin, E. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00495.2010 · Cited by 223
Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction
Johansson, J., & Stener‐Victorin, E. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/762615 · Cited by 150
Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial
Johansson, J., Redman, L., Veldhuis, P. P., Sazonova, A., Labrie, F., Holm, G., Johannsson, G., & Stener-Victorin, E. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00039.2013 · Cited by 131
Androgens and polycystic ovary syndrome
Nisenblat, V., & Norman, R. J. (2009) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32832afd4d · Cited by 125
Metadata
- Authors
- Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A.
- Affiliations
- Benha University (EG)
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-07-29
- Volume
- 23
- Issue
- 11
- Pages
- 2564-2569
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2156291382
- Cited by
- 58
- References
- 53
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 4 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 3 · 2016: 3 · 2014: 3 · 2013: 7 · 2012: 2
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Reproduction (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- naltrexone, polycystic ovary syndrome, clomiphene citrate resistance, opioid system, ovulation induction, infertility, hyperandrogenism, hyperinsulinemia, luteinizing hormone, testosterone, body mass index, pregnancy outcomes
- MeSH terms
- Adolescent, Adult, Analgesics, Opioid, Clomiphene, Drug Resistance, Estrogen Antagonists, Female, Humans, Infertility, Female, Luteinizing Hormone, Naltrexone, Narcotic Antagonists, Polycystic Ovary Syndrome, Pregnancy, Body Mass Index, Pregnancy Rate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1093/humrep/den273
- The paper
- Ahmed, M. I., Duleba, A. J., El Shahat, O., Ibrahim, M. E., & Salem, A. (2008). Naltrexone treatment in clomiphene resistant women with polycystic ovary syndrome. Human Reproduction. https://doi.org/10.1093/humrep/den273
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.